Jimenez-Rodriguez, Rosa M ; Martín-Gutiérrez, Guillermo ; Jiménez-Jorge, Silvia... The REJUVENATE trial was supported by Innovative Medicines Initiative (IMI) Combatting Bacterial Resistance in Europe-Carbapenem-Resistance COMBACTE-CARE WP2B (G.A. 115620). Plan Nacional de I+D+i 2013‐2016 (Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Ciencia, Innovación y Universidades, Spanish Network for Research in Infectious Diseases-REIPI) with the grants RD16/0016/009; RD16/0016/0008; RD16/0016/0001; RD16/0016/0015; RD16/0016/0004; RD16/0016/0012. The study was supported by the SCReNSpanish Clinical Research Network (PT13/0002/0010-PT17/0017/0012) from the National R+D+I Plan of the Institute of Health Carlos III (Ministerio de Ciencia, Innovación y Universidades)..
,
2022
Cornely, Oliver A ; Cisneros, José M ; Torre-Cisneros, Julian... Cornely OA, Cisneros JM, Torre-Cisneros J, Rodríguez-Hernández MJ, Tallón-Aguilar L, Calbo E, et al. Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study. J Antimicrob Chemother. 2020 Mar 1; 75(3):618-27. DOI:10.1093/jac/dkz497.
,